CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 64.471
AS - Asia 27.207
EU - Europa 18.253
SA - Sud America 3.926
Continente sconosciuto - Info sul continente non disponibili 2.184
AF - Africa 561
OC - Oceania 63
Totale 116.665
Nazione #
US - Stati Uniti d'America 59.986
SG - Singapore 9.805
IT - Italia 5.063
CN - Cina 4.910
HK - Hong Kong 4.713
VN - Vietnam 3.810
CA - Canada 3.706
RU - Federazione Russa 3.485
BR - Brasile 2.973
IE - Irlanda 1.995
UA - Ucraina 1.618
SE - Svezia 1.580
DE - Germania 1.244
GB - Regno Unito 1.009
BD - Bangladesh 989
FR - Francia 889
IN - India 595
FI - Finlandia 484
AR - Argentina 355
TR - Turchia 326
ID - Indonesia 302
IQ - Iraq 285
KR - Corea 281
MX - Messico 200
PK - Pakistan 174
EC - Ecuador 173
ZA - Sudafrica 160
NL - Olanda 144
CO - Colombia 139
JP - Giappone 136
SA - Arabia Saudita 134
PH - Filippine 112
AT - Austria 109
UZ - Uzbekistan 104
ES - Italia 99
PL - Polonia 98
VE - Venezuela 92
CR - Costa Rica 84
DK - Danimarca 83
MY - Malesia 80
JM - Giamaica 78
CL - Cile 65
MA - Marocco 65
GT - Guatemala 63
SV - El Salvador 62
TT - Trinidad e Tobago 58
EG - Egitto 57
HN - Honduras 57
KE - Kenya 56
TN - Tunisia 50
AU - Australia 48
PY - Paraguay 48
NI - Nicaragua 47
TH - Thailandia 47
BE - Belgio 44
CZ - Repubblica Ceca 44
AE - Emirati Arabi Uniti 41
NP - Nepal 41
PR - Porto Rico 40
ET - Etiopia 38
DZ - Algeria 33
IL - Israele 29
JO - Giordania 29
GP - Guadalupe 28
PE - Perù 28
CW - ???statistics.table.value.countryCode.CW??? 27
LT - Lituania 27
RO - Romania 27
AZ - Azerbaigian 26
KZ - Kazakistan 26
OM - Oman 26
UY - Uruguay 24
IR - Iran 23
BO - Bolivia 22
EE - Estonia 22
NG - Nigeria 22
PS - Palestinian Territory 22
BG - Bulgaria 21
TW - Taiwan 21
GR - Grecia 19
RS - Serbia 18
AL - Albania 17
DO - Repubblica Dominicana 16
KG - Kirghizistan 16
LB - Libano 16
PT - Portogallo 15
SN - Senegal 15
HU - Ungheria 14
NZ - Nuova Zelanda 14
CH - Svizzera 13
GE - Georgia 13
BA - Bosnia-Erzegovina 11
BH - Bahrain 11
BY - Bielorussia 11
EU - Europa 11
PA - Panama 11
QA - Qatar 11
SY - Repubblica araba siriana 11
LK - Sri Lanka 10
NO - Norvegia 10
Totale 114.339
Città #
Ann Arbor 7.848
Ashburn 5.423
Singapore 5.146
Hong Kong 4.662
Woodbridge 4.364
Fairfield 4.241
Houston 3.152
Toronto 2.854
San Jose 2.552
Dublin 1.877
Jacksonville 1.840
Wilmington 1.833
Milan 1.800
Seattle 1.671
Council Bluffs 1.437
Cambridge 1.399
Chandler 1.365
Dearborn 1.365
New York 1.302
Ho Chi Minh City 1.133
Princeton 1.007
Chicago 963
Santa Clara 910
Hanoi 878
Dallas 840
The Dalles 775
Beijing 667
Frankfurt am Main 656
Los Angeles 641
Hefei 534
Lauterbourg 497
Lawrence 479
Rome 479
Altamura 453
Nanjing 423
Moscow 328
San Diego 323
Lachine 310
São Paulo 286
Seoul 256
Buffalo 231
Boardman 202
Dong Ket 171
Phoenix 170
Shanghai 169
Guangzhou 156
Jakarta 154
Nanchang 146
Shenyang 145
Salt Lake City 144
Andover 139
Da Nang 139
Columbus 138
Atlanta 134
Haiphong 130
London 129
Figino 122
Hebei 120
Baghdad 116
Orem 116
Helsinki 110
Washington 108
Turin 102
North Bergen 101
Denver 98
Montreal 98
Falls Church 95
Munich 95
Ottawa 95
Rio de Janeiro 94
Tianjin 94
Brooklyn 90
Naples 90
Norwalk 90
Changsha 89
Tokyo 89
Detroit 88
Tampa 87
Tashkent 85
Philadelphia 83
Jiaxing 81
San Francisco 81
Nuremberg 77
Quito 76
Miami 71
Jinan 66
Warsaw 66
Dhaka 65
Hangzhou 65
Brasília 64
Chennai 62
Johannesburg 62
San José 62
Vienna 62
Newark 61
Can Tho 58
Biên Hòa 57
Zhengzhou 55
Charlotte 54
Hải Dương 53
Totale 75.119
Nome #
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 790
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 642
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 511
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 508
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 401
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 400
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 393
Need for information and locus of control among hypertensive patients 382
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 369
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 368
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 365
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 360
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 356
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 352
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 351
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 348
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 347
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 345
Cardiopulmonary receptor regulation of renin release 344
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 342
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 330
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 328
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 327
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 326
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 324
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 323
Neurogenic abnormalities in masked hypertension 321
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 321
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 318
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 316
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 315
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 314
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 311
Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age 307
Renal and antihypertensive effects of felodipine in hypertensive patients 307
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 302
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 302
New onset left atrial dilatation in the general population: A quarter-century follow-up 300
New-onset left atrial enlargement in a general population 300
Extreme dipping: Always means nocturnal hypotension? 300
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 298
Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies 298
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 297
The association between 24-h blood pressure patterns and left ventricular mechanics 296
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 292
Elevated Blood Pressure And Cardiac Mechanics In Children And Adolescents: A Systematic Review And Meta-Analysis 291
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 291
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 290
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study 288
Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian survey 287
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 287
Treatment of hypertension: The ESH/ESC guidelines recommendations 287
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 284
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 284
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 280
Nocturnal blood pressure in untreated essential hypertensives 279
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 279
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 278
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 277
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 277
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 277
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 276
Blood pressure control in hypertension. Pros and cons of available treatment strategies 276
Metabolic syndrome and multiple organ damage in essential hypertension 275
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 275
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 274
Comprendere l'ipertensione; percezioni della malattia e bisogno informativo in un campione di pazienti ipertesi 274
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 272
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 271
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 271
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 270
Evaluating a tailored message intervention for improving hypertension outcomes 268
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 266
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives? 266
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 265
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 264
Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis 263
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 262
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 262
Clinical evaluation of a new antihypertensive drug (Indapamide) 262
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 261
Home and ambulatory blood pressure in resistant hypertension 261
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 260
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 260
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 260
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 260
Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension 259
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 259
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 259
Incident Left Ventricular Hypertrophy in Masked Hypertension 259
Is retinal arteriolar-venular associated with cardiac and extracardiac organ damage in essential hypertension? 258
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 256
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 254
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 254
Metabolic syndrome and target organ damage: Role of blood pressure 252
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 252
How does subclinical hyperthyroidism affect right heart function and mechanics? 251
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 249
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 248
Evaluating a tailored message intervention for improving hypertension outcomes 245
Totale 30.812
Categoria #
all - tutte 384.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 384.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.378 0 0 0 444 393 369 359 406 416 382 515 1.094
2022/20236.284 1.085 1.785 392 401 366 1.082 83 307 403 69 213 98
2023/20245.325 143 112 112 187 918 1.380 964 84 741 105 57 522
2024/202514.957 922 1.946 411 671 1.382 386 520 484 2.090 1.930 1.358 2.857
2025/202637.091 3.561 2.468 2.740 3.195 3.564 1.899 4.605 1.756 2.701 2.686 4.272 3.644
2026/202712.296 1.244 1.542 4.577 4.933 0 0 0 0 0 0 0 0
Totale 116.665